Literature DB >> 8214323

Anticardiolipin antibody-induced sudden profound sensorineural hearing loss.

K Hisashi1, S Komune, T Taira, T Uemura, S Sadoshima, H Tsuda.   

Abstract

INTRODUCTION: A link between sensorineural hearing loss (SNHL) and autoimmune disease is postulated. The association of SNHL in a patient with systemic lupus erythematosus is reported.
METHODS: An adolescent female with left lateral medullary syndrome and right internuclear ophthalmoplegia was diagnosed with systemic lupus erythematosus. Treatment with prednisolone markedly improved her symptoms. Two years later, profound SNHL developed in the right ear. Extensive serologic testing was undertaken.
RESULTS: Serologic tests for syphilis were false-positive. Enzyme-linked immunosorbent assay to the immunoglobulin (Ig)G anticardiolipin antibody was positive. The anticardiolipin antibody is strongly correlated with episodes of recurrent venous or arterial thrombosis.
CONCLUSIONS: It appears that the anticardiolipin antibody may be associated with sudden profound sensorineural hearing loss in patients with autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214323     DOI: 10.1016/0196-0709(93)90075-i

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  13 in total

1.  Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies.

Authors:  S Kremmer; E Kreuzfelder; E Bachor; K Jahnke; J M Selbach; S Seidahmadi
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

2.  Antiphospholipid antibodies in patients with sensorineural hearing loss.

Authors:  Edgar Bachor; Stephan Kremmer; Ernst Kreuzfelder; Klaus Jahnke; Said Seidahmadi
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-02-25       Impact factor: 2.503

3.  Increased risk of sudden sensory neural hearing loss in patients with rheumatoid arthritis: a longitudinal follow-up study using a national sample cohort.

Authors:  Sang-Yeon Lee; Il Gyu Kong; Dong Jun Oh; Hyo Geun Choi
Journal:  Clin Rheumatol       Date:  2018-10-15       Impact factor: 2.980

Review 4.  Function of the audiovestibular system in children with systemic lupus erythematosus.

Authors:  Ghada Ibrahim Gad; Hanan Abdelateef
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

Review 5.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

6.  Hearing loss in patients with systemic lupus erythematosus.

Authors:  Mahnaz Abbasi; Zohreh Yazdi; Amir Mohammad Kazemifar; Zahra Zarin Bakhsh
Journal:  Glob J Health Sci       Date:  2013-06-15

7.  Examination of Hearing in a Rheumatoid Arthritis Population: Role of Extended-High-Frequency Audiometry in the Diagnosis of Subclinical Involvement.

Authors:  Mar Lasso de la Vega; Ithzel Maria Villarreal; Julio Lopez-Moya; Jose Ramon Garcia-Berrocal
Journal:  Scientifica (Cairo)       Date:  2016-04-27

8.  Sudden Sensorioneural Hearing Loss and Autoimmune Systemic Diseases.

Authors:  Bruno Almeida Antunes Rossini; Norma de Oliveira Penido; Mario Sergio Lei Munhoz; Eduardo Amaro Bogaz; Renata Souza Curi
Journal:  Int Arch Otorhinolaryngol       Date:  2016-07-26

9.  Comparisons of clinical manifestations and prognosis between giant cell arteritis patients with or without sensorineural hearing loss: A retrospective study of Chinese patients.

Authors:  Xiaotian Chu; Dongmei Wang; Yun Zhang; Yue Yin; Yu Cao; Xinxin Han; Min Shen; Hong Jiang; Xuejun Zeng
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 10.  Bilateral sudden sensorineural hearing loss as a presenting feature of systemic lupus erythematosus: Case report and brief review of other published cases.

Authors:  Sylvain Chawki; Jessie Aouizerate; Selim Trad; Jacques Prinseau; Thomas Hanslik
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.